Director of AI Strategy & Operations, Prenuvo
CA$212-319k
Whole body MRI scans
Be an early applicant
Whole body MRI scans
201-500 employees
Be an early applicant
CA$212-319k
201-500 employees
Company mission
Prenuvo's mission is to transform the medical paradigm from reactive to proactive, ridding the world of advanced disease by detecting it early when treatment is easiest and most successful.
Role
Who you are
- 7–10+ years of experience in high ownership environments requiring a blend of strategy and execution - examples could be time in strategy consulting, research commercialisation, product or program management, or founder roles
- Experience leading cross-functional programs that span R&D, clinical/regulatory, and go-to-market
- Clear and impactful communication skills: You write and speak with clarity, distilling complex information into actionable insights. You’re effective in engaging with executives and driving alignment at the leadership level
- Deep operational rigor: you’ve run cadences, tracked KPIs, built status reporting, and held teams accountable to deliverables
- High EQ and collaborative leadership style: you know how to work with scientists, engineers, and execs without friction
- Detail-oriented with strategic insight: You can dive into the small details without losing sight of the bigger picture, shaping narratives that guide decision-making
What the job involves
- We are looking for a Director of AI Strategy & Operations, you will serve as the strategic and operational partner to the VP of AI and Research
- This is a high-impact role that combines strategic planning, program execution, cross-functional orchestration, and leadership accountability to define and drive forward Prenuvo’s most critical AI initiatives—from research and labeling infrastructure to regulatory delivery and product deployment
- You’ll act as the connective tissue across research, clinical, engineering, and regulatory, ensuring our AI roadmap translates into execution with speed, clarity, and accountability
- Act as a thought partner for the VP of AI - helping to plan the roadmap of initiatives that will deliver the most impact for Prenuvo and our patients
- Drive execution of Prenuvo’s end-to-end AI portfolio—including research programs, labeling initiatives, FDA-regulatory workflows, and model deployment readiness
- Build and lead an AI program operating model, including team cadences, prioritization processes, and executive reporting
- Own upward communication—synthesizing complex AI/technical updates into crisp, business-aligned narratives for the CEO, CMO, and board audiences
- Collaborate deeply with labeling leads, radiology experts, AI scientists, and software/product managers to set clear OKRs and resource plans
- Monitor progress against KPIs and proactively identify blockers, risks, or misalignments—ensuring a “no surprises” environment for AI execution
- Lead strategic problem-solving in ambiguous areas—e.g., labeling throughput, regulatory preparation, clinical readiness—without waiting to be told what to do
- Instill a culture of 80/20 thinking, fast iteration, and tight alignment across research teams
Our take
The quantified self movement is gaining momentum, especially in the health and fitness sector. Wearable health monitors, sleep trackers, and genetic testing have all firmly entered the mainstream, and body MRI scanning service Prenuvo is taking this concept to the next level. Prenuvo’s whole body diagnostic imaging offers customers a comprehensive picture of their body, whilst screening for 500+ major conditions and cancers.
The medical benefits of approaching these diseases proactively, as opposed to reactively, are substantial. Customers will be able to catch warning signs early, meaning treatment is likely to be less invasive, with a higher success rate. Unfortunately North America, like many regions, has yet to make substantial investments in preventative healthcare. This just makes companies like Prenuvo, and the VCs who fund them, increasingly necessary.
This funding, however has been substantial, and having closed a Series A funding round in 2022 Prenuvo has moved swiftly to open new clinics across the United States. Its next step is to improve the accessibility of its service - currently scans cost about $1000, but improvements in the technology and working processes will cut the cost by two thirds or more and greatly expand Prenuvo's addressable market.
Steph
Company Specialist at Welcome to the Jungle
Insights
Company
Funding (2 rounds)
Dec 2024
$120m
SERIES B
Oct 2022
$56m
SERIES A
Total funding: $176m
Company benefits
- Save Lives: Early detection is key to healthier lives. We do the incredibly rewarding work of giving people the information they need, as early as possible
- Social Events: Building strong relationships is at the core of everything we do. Our team gets together each week to connect, share, and socialize
- Full Body Scans: We believe in preventative healthcare for everyone, including our team. Prenuvo provides free, whole-body scans to each team member
- Coffee & Snacks: Daily health at Prenuvo means having space to take a break and refuel. We keep our break room stocked with coffee and healthy snacks
- We offer a comprehensive benefits package including health, dental, vision, including Mental Health coverage, and an Employee and Family Assistance Program to support you and your family
- Recognizing time away to restore is vital to our wellbeing - we have a flexible vacation policy and we will encourage you to use it
- Growth opportunities are at the heart of our people journey, we’re doing big things with bright minds - there is no single path to success, it can be shaped along the way
Leadership
Andrew Lacy
(CEO)Previously founded semantic search company Zaptravel (now Lebara Travel) and iPhone app company Tapulous (subsequently sold to Disney). Later joined Disney as the SVP of Disney Mobile, and then Lebara as Chief Product Officer. Alongside work at Prenuvo they also co-founded Azarus.
Share this job
View 20 more jobs at Prenuvo